Unknown

Dataset Information

Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial.


ABSTRACT:

SUBMITTER: Kantarjian HM 

PROVIDER: S-EPMC5925750 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature